North Dakota 2023-2024 Regular Session

North Dakota Senate Bill SB2248

Introduced
1/13/23  
Refer
1/13/23  
Report Pass
1/31/23  
Refer
2/1/23  
Report Pass
2/16/23  
Engrossed
2/17/23  
Refer
2/21/23  
Report Pass
3/21/23  
Refer
3/22/23  
Report Pass
4/7/23  
Enrolled
4/27/23  

Caption

A special penalty for death or injury through distribution of illegal drugs and fentanyl reporting; to provide a statement of legislative intent regarding fentanyl awareness expansion; and to provide a penalty.

Impact

By creating a framework for prosecuting those who distribute illegal drugs in circumstances where it leads to an overdose, SB2248 aims to deter drug distribution and enhance public safety. This includes the requirement for the Department of Health and Human Services to report annually on fentanyl-related deaths, making the information public through reports, campaigns, and visibility initiatives. The legislation seeks not only to penalize wrongdoing but also to foster community awareness and education on the dangers of fentanyl, projecting an increase in state accountability concerning substance abuse issues.

Summary

Senate Bill No. 2248 was introduced to address the grave issue of illegal drug distribution, particularly focusing on fentanyl. This bill enacts a special penalty for individuals whose distribution of illegal drugs results in death or injury to others. Specifically, it establishes that if someone willfully supplies a controlled substance leading to another individual's fatal overdose or serious injury, they can face considerable legal ramifications under a class A felony charge. The bill reflects a strong legislative intent to combat the growing problem of fentanyl-related deaths and injuries in North Dakota.

Sentiment

The sentiment surrounding Senate Bill No. 2248 appears overwhelmingly supportive, with unanimous votes in favor during its legislative journey. Both the Senate and the House saw no opposition to the bill, indicating strong consensus on the need for tougher measures against drug distribution linked to fentanyl overdoses. This widespread agreement suggests a collective acknowledgment of the opioid crisis in North Dakota and a commitment to taking actionable steps to protect the community.

Contention

Although SB2248 has garnered widespread support, some areas of contention may arise around the specifics of implementation and enforcement. Questions about equitable enforcement and potential unintended consequences, such as over-policing marginalized communities or the adequacy of resources for addiction treatment, may surface as the bill is put into practice. Additionally, the effectiveness of public awareness campaigns in genuinely changing behaviors and reducing overdose rates may also be scrutinized as milestones are assessed post-implementation.

Companion Bills

No companion bills found.

Similar Bills

CA SB19

Fentanyl Misuse and Overdose Prevention Task Force.

CA AB1673

California Fentanyl Abuse Task Force.

CA AB33

Fentanyl Misuse and Overdose Prevention Task Force.

DE SB189

An Act To Amend Title 16 Of The Delaware Code Relating To The Uniform Controlled Substances Act And Drug Testing Strips.

CA AB3224

California Fentanyl Abuse Task Force.

CA AB3171

Controlled substances: fentanyl.

LA SB315

Provides relative to fentanyl and carfentanil. (8/1/22) (EN INCREASE GF EX See Note)